Skip to main content

Alpha-parvin/Actopaxin Antibody [PerCP]

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-00221PCP

Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Human

Applications

ELISA

Label

PerCP (Excitation = 490 nm, Emission = 675 nm)

Antibody Source

Polyclonal Rabbit IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Produced in rabbits immunized with purified, recombinant Human Alpha-parvin/Actopaxin (Uniprot#: Q9NVD7-1; Met1-Glu372).

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Applications for Alpha-parvin/Actopaxin Antibody [PerCP]

Application
Recommended Usage

ELISA

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen and protein A Affinity-purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: alpha-Parvin

Members of the parvin family, including Actopaxin, are actin-binding proteins associated with focal contacts.[supplied by OMIM]

Alternate Names

Actopaxin, alphaParvin, CH-ILKBP, MXRA2, PARVA

Gene Symbol

PARVA

Additional alpha-Parvin Products

Product Documents for Alpha-parvin/Actopaxin Antibody [PerCP]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Alpha-parvin/Actopaxin Antibody [PerCP]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...